Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sovaldi Among New HCV Drugs In Turkey Reimbursement Pact

This article was originally published in PharmAsia News

Executive Summary

Turkey’s public health payer has added three new hepatitis C drugs to the reimbursement list through a special deal with manufacturers, although the price the SGK will be paying to the companies is not being revealed.

You may also be interested in...



How Might Turkey Contain Its Rising Health Care Bill?

As Turkey’s government discloses health care and drug budget plans for 2017, it is becoming clear that controlling the rise in national costs while meeting needs will remain central to policies, prompting the consideration of a variety of approaches.

Turkey’s $2.6Bn Hospital Medtech Debts Create Problems On Top Of COVID-19

Turkey’s efforts to control rising rates of COVID-19 are compromising the ability of hospitals to pay their debts to medtech and pharmaceutical companies. The government has devised a payments plan, but there is catch.

COVID-19 Pushes Ongoing Concerns of Turkish Medtech Industry Down The Agenda

The Turkish medtech industry’s ongoing hospital payments problems appeared likely to come back onto the government’s agenda, with the national economy recovering somewhat in late 2019. But COVID-19 dashed those hopes.

Topics

Related Companies

UsernamePublicRestriction

Register

OM003387

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel